Cannabis flowers are indispensable – why a ban would be harmful

Quick overview

• Fast & controllable: Inhaled flowers take effect within minutes – crucial for acute pain, cramps, nausea.

• Legally permissible: In Germany , dried flowers , extracts and dronabinol/nabilone can be prescribed – with clear G-BA rules.

• Political initiatives: Current proposals aim to restrict telemedicine/mail-order services; in some cases, a ban on flowering is even being demanded – associations are warning against this.

• Supply reality: The demand is high: In 2024, >72 tons of flowers were imported for medical/scientific purposes.

1) Medical necessity: Why flowers must remain

1.1 Fast, titratable effect (minutes instead of hours)

When inhaled, THC levels and effects rise significantly faster than with oral administration. Studies show that vaporization produces stronger pharmacodynamic effects at the same dose as smoking; overall, the effect sets in within minutes (peak 15–30 min), often lasting 2–4 h. This is clinically relevant for breakthrough pain , spastic cramps , migraines , or chemotherapy-induced nausea .

1.2 Inhalation without combustion = fewer pollutants

Vaporizers deliver active ingredients without combustion , thus reducing pyrolysis products compared to smoking. Even classic studies with medical vaporizers (e.g., Volcano) demonstrate this harm reduction advantage . Current reviews on cannabis vaporization confirm this basic principle.

1.3 Customizability & Entourage Effects

Flowers contain the complete phytocomplex profile (cannabinoids, terpenes, flavonoids). Physicians can select the strain, THC/CBD range, and terpene profile tailored to the patient and finely titrate the dose via inhalation frequency/temperature —something that standardized, purely oral preparations can only offer to a limited extent. (The evidence for the "entourage hypothesis" is heterogeneous; however, clinical experience and patient-reported outcomes support its benefit in individual cases.)

2) Legal situation & care in Germany (as of 2025)

• Prescribable items include: dried flowers , extracts , and finished medicinal products dronabinol/nabilone . Initial prescription/major change in therapy : approval from the health insurance fund is required; subsequent prescriptions generally do not require renewed approval.

• MedCanG 2024 provided organizational relief for the regulation; at the same time, import volumes are increasing sharply (supply needs).

• KBV note: Finished medicinal products take precedence over tinctures – but tinctures remain permissible if medically justified (e.g., the need for a rapid, easily controllable effect). This is important for maintaining therapeutic autonomy.

3) Political debate: What is currently being discussed

• BMG draft bill (2025): Mandatory personal doctor contact, ban on mail-order prescriptions , restrictions on telemedicine/e-prescriptions for medicinal cannabis. Criticized due to supply barriers and concerns regarding EU law.

• The idea of ​​a "ban on flowering drugs": Individual actors are demanding that flowering drugs no longer be permitted; industry and professional associations warn of massive disadvantages for patients (delay in effect, poorer controllability, pushing patients into unofficial channels).

Assessment: Instead of blanket bans , indication- and patient-oriented decisions are needed . A blanket ban would particularly affect patients who depend on fast-acting, flexible application.

4) Evidence Update: What Studies Say about Inhalation & Vaporizer

Important: The overall evidence on effectiveness in individual indications is heterogeneous; this is precisely why more research is needed – not fewer treatment options.

5) Why extract flowers not fundamentally replace

1. Onset & Controllability: Oral extracts take 30–90 minutes to take effect – bad for breakthrough situations; inhaled flower takes effect in minutes.

2. Fine titration: The flowering stage allows the dose to be adjusted in small steps to the daily condition/pain peaks.

3. Tolerability & Preference: Many patients report fewer side effects and better everyday control with Blüte (clinical practice reports, PROs).

4. Therapeutic autonomy: Guidelines (KBV/G-BA) yes – blanket bans no. Physicians must be able to choose in individual cases.

6) Risks of a prohibition/restriction policy

• Supply bottlenecks and delays (medical procedures, mandatory pharmacy dispensing without mail order, reduced telemedicine).

• Forced into unofficial markets in acute pain situations when legal quick options are lacking.

• Inequality (city vs. country): Patients with long journeys are hit harder.

• Loss of trust in an already fragile healthcare system – and therefore poorer adherence.

7) Practical: How patients use flowers responsibly (with medical supervision)

• Application: Vaporizer instead of smoking (healthier, more discreet, more precise).

• Settings: Start with a low temperature , increase slowly; keep a symptom diary (onset, duration, side effects).

• Combination: In chronic cases, possibly oral (baseline level) + inhalation (breakthrough) – plan according to medical advice.

• Compliance & Safety: Do not participate in road traffic while under acute effect; check interactions; conduct regular progress checks.

8) Policy recommendations

• Preserving flowers – as a clearly justifiable option for fast, titratable relief.

• Ensuring quality – laboratory controls, standardization, devices with reliable temperature control.

• Facilitating care – digital consultations and structured shipping routes for suitable cases instead of blanket bans.

• Promoting research – Indication-specific RCTs, real-world data & registries.

FAQ

Are cannabis flowers permitted as medicine in Germany?
Yes. dried flowers, Extracts and Dronabinol/NabiloneSpecific G-BA rules apply to initial/follow-up prescriptions. 

Do flowers really work faster than drops/capsules?
Yes. Inhalation leads to Minutes to measurable effects; oral takes 30–90 min. – for breakthrough situations the difference is clinically relevant. 

Is vaping healthier than smoking?
Heating vaporizers without combustion → fewer pollutants than with a joint. 

What does the new draft change?
Planned are, among others: Obligation to contact a doctor personally and Shipping banExperts criticise this as being hostile to healthcare provision and partly questionable under EU law. 

Conclusion

Cannabis flowers are not a relic – they are medically necessary.
they offer fast, finely controllable Relief and enable a individualized Therapy where oral medications are too slow or difficult to titrate. A blanket ban would deprive patients of real options, worsen care, and undermine therapeutic sovereignty. The right approach is educate, ensure quality and improve evidence-based – not prohibit.